AstraZeneca Aktie
122,70
EUR
-1,15
EUR
-0,93
%
101,44
GBP
-1,00
GBP
-0,98
%
AstraZeneca Aktie Analyse
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.08.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.07.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca overweight | Barclays Capital | |
| 26.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.07.19 | AstraZeneca Outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 25.07.19 | AstraZeneca Sell | UBS AG | |
| 25.07.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.07.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.07.19 | AstraZeneca buy | Deutsche Bank AG | |
| 27.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 27.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 17.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.06.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca buy | Deutsche Bank AG | |
| 04.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.06.19 | AstraZeneca Sell | UBS AG | |
| 28.05.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.05.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 24.05.19 | AstraZeneca overweight | Barclays Capital | |
| 13.05.19 | AstraZeneca Sell | UBS AG | |
| 13.05.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 10.05.19 | AstraZeneca buy | Deutsche Bank AG | |
| 10.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.05.19 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 07.05.19 | AstraZeneca Sell | UBS AG | |
| 07.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.04.19 | AstraZeneca Sell | UBS AG | |
| 26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.04.19 | AstraZeneca Sell | UBS AG | |
| 02.04.19 | AstraZeneca Reduce | HSBC | |
| 01.04.19 | AstraZeneca overweight | Barclays Capital | |
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.03.19 | AstraZeneca overweight | Barclays Capital | |